Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex

Experimental Neurology

Volumn 182, Issue 1, 2003, Pages 220-231

  Bu, Jing ^a   Sathyendra, Vikram ^a   Nagykery, Nicholas ^a   Geula, Changiz ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Acetylcholinesterase; Aging; Calbindin; Calretinin; Human cortex; Nonphosphorylated neurofilament; Parvalbumin

Indexed keywords

ACETYLCHOLINESTERASE; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADULT; AGE; AGED; AGING; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL COUNT; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; MALE; NERVE CELL; NEUROCHEMISTRY; NEUROFILAMENT; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION;

EID: 0038434115     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00094-3     Document Type: Article

References (56)

1. Ang L.C., Shul D.D. Peptidergic neurons of subcortical white matter in aging and Alzheimer's brain. Brain Res. 674:1995;329-335.
2. Arnold S.E., Hyman B.T., Van Hoesen G.W. Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease. Arch Neurol. 51:1994;145-150.
3. Baimbridge K.G., Celio M.R., Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurosci. 15:1992;303-308.
4. Blaustein M.P. Calcium transport and buffering in neurons. Tends Neurosci. 11:1988;438-448.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 82:1991;239-259.
6. 2+ homeostasis. Ann. Rev. Biochem. 56:1987;395-433.
7. Clapham D.E. Calcium signaling. Cell. 80:1995;259-268.
8. Diop A.G., Lesort M., Esclaire F. Calbindin D28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures. J. Neurosci. Res. 42:1995;252-258.
9. Fineman I., Hovda D.A., Smith M. Concussive brain injury is associated with a prolonged accumulation of calcium a 45Ca autoradiographic study . Brain Res. 624:1993;94-102.
10. German D.C., Manaye K., Smith W.K. Midbrain dopaminergic cell loss in Parkinson's disease computer visualization . Ann. Neurol. 26:1989;507-514. [see comments].
11. German D.C., Manaye K.F., Sonsalla P.K., Brooks B.A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism sparing of calbindin-D28k-containing cells . Ann. N. Y. Acad. Sci. 648:1992;42-62.
12. Geula C., Mesulam M.-M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb. Cortex. 6:1996;165-177.
13. Geula C., Mesulam M.-M., Saroff D.M., Wu C.-K. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 57:1998;63-75.
14. Geula, C., Mesulam, M.-M., 1999. Cholinergic systems in Alzheimer's disease, in: Terry, R.D., Katzman, R., Bick, K.L., Sisodia, S.S. (Eds.), Alzheimer's Disease, Lippincott Williams & Wilkins, Philadelphia, pp. 269-292.
15. Geula C. Pathological diagnosis of Alzheimer's disease. Scinto L.F.M., Daffner K.R. Early Diagnosis of Alzheimer's Disease. 2000;65-82 Humanna Press, Totowa, NJ.
16. Geula C., Bu J., Nagykery N., Scinto L.F.M., Chan J., Parker R., Joseph J., Wu C.-K. Calbindin-D28K loss from aging human cholinergic basal forebrain relation to neuronal loss . J. Comp. Neurol. 455:2003;249-259.
17. Ghosh A., Greenberg M.E. Calcium signaling in neurons molecular mechanisms and cellular consequences . Science. 268:1995;239-247.
18. Giannakopoulos P., Hof P.R., Kovari E., Vallet P.G., Herrmann F.R., Bouras C. Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J. Neuropathol. Exp. Neurol. 55:1996;1210-1220.
19. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;491-500.
20. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41:1997;17-24.
21. Heizmann C.W., Braun K. Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15:1992;259-264.
22. Hugon J., Hugon F., Esclaire F. The presence of calbindin in rat cortical neurons protects in vitro from oxidative stress. Brain Res. 707:1996;288-292.
23. Iacopino A., Christakos S.D., German P., Sonsalla K., Altar C.A. Calbindin-D28K-containing neurons in animal models of neurodegeneration possible protection from excitotoxicity . Mol. Brain. Res. 13:1992;251-261.
24. Iacopino A.M., Quintero E.M., Miller E.K. Calbindin-D28K a potential neuroprotective protein . Neurodegeneration. 3:1994;1-20.
25. Idrizbegovic E., Viberg A., Bogdanovic N., Canlon B. Peripheral cell loss related to calcium binding protein immunocytochemistry in the dorsal cochlear nucleus in CBA/CaJ mice during aging. Audiol. Neurootol. 6:2001;132-139.
26. Khachaturian Z.S. Calcium hypothesis of Alzheimer's disease and brain aging. Ann. N. Y. Acad. Sci. 747:1984;1-11.
27. Khachaturian Z.S. The role of calcium regulation in brain aging re-examination of a hypothesis . Aging. 1:1989;17-34.
28. Kirischuk S., Verkhratsky A. Calcium homeostasis in aged neurones. Life Sci. 59:1996;451-459.
29. Kishimoto J., Tsuchiya T., Cox H., Emson P.C., Nakayama Y. Age-related changes of calbindin-D28k, calretinin, and parvalbumin mRNAs in the hamster brain. Neurobiol. Aging. 19:1998;77-82.
30. Koelle G.B., Friedenwald J.S. A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. Med. 70:1949;617-622.
31. Kostovic I., Rakic P. Cytology and time of origin of interstitial neurons in the white matter in infant and adult human and monkey telencephalon. J. Neurocytol. 9:1980;219-242.
32. Leuba G., Kraftsik R. Visual cortex in Alzheimer's disease occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks . Neurobiol. Aging. 15:1994;29-43.
33. Martinez A., Vitorica J., Satrustegui J. Cytosolic free calcium levels increase with age in rat brain synaptosomes. Neurosci. Lett. 88:1988;336-342.
34. Mattson M.P., Rychlik B., Chu C., Christakos S. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron. 6:1991;41-51.
35. Mattson M.P., Rydel R.E., Lieberburg I., Smith-Swintosky V.L. Altered calcium signaling and neuronal injury stroke and Alzheimer's disease as examples . Ann. N. Y. Acad. Sci. 679:1993;1-21.
36. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., Rydel R.E. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
37. Mesulam M.-M., Geula C. Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus absence at birth, development during the life span, and dissolution in Alzheimer's disease . Ann. Neurol. 24:1988;765-773.
38. Mesulam M.-M., Geula C. Acetylcholinesterase-rich neurons of the human cerebral cortex cytoarchitectonic and ontogenetic patterns of distribution . J. Comp. Neurol. 306:1991;193-220.
39. Meyer G., Wahle P., Castaneyra-Perdomo A., Ferres-Torres R. Morphology of neurons in the white matter of the adult human neocortex. Exp. Brain Res. 88:1992;204-212.
40. 2+ homeostasis. Prog. Neurobiol. 37:1991;255-285.
41. Miller R.J. Regulation of calcium homeostasis in neurons the role of calcium-binding proteins . Biochem. Soc. Trans. 23:1995;629-632.
42. Muller W.E., Gispen W.H. The current status of the calcium hypothesis of brain aging and Alzheimer's Disease. Life Sci. 59:1996;357-510.
43. 2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol. Lett. 357:1992;64-65.
44. Orrenius S., Nicotera P. The calcium ion and cell death. J. Neural. Transm. (Suppl.):1994;1-11.
45. Phillips R.G., Meier T.J., Giuli L.C., McLaughlin J.R., Ho D.Y., Sapolsky R.M. Calbindin D28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults. J. Neurochem. 73:1999;1200-1205.
46. Rojiani A.M., Emery J.A., Anderson K.J., Massey J.K. Distribution of heterotopic neurons in normal hemispheric white matter a morphometric analysis . J. Neuropathol. Exp. Neurol. 55:1996;178-183.
47. Scharfman H.E., Schwartzkroin P.A. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science. 246:1989;249-262.
48. Scherer-Singler U., Vincent S.R., Kimura H., McGeer E.G. Demonstration of a unique population of neurons with NADPH-diaphorase histochemistry. J. Neurosci. Methods. 9:1983;229-234.
49. Selden N., Geula C., Hersh L., Mesulam M.-M. Human striatum chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease . Neuroscience. 60:1994;621-636.
50. Shetty A.K., Turner D.A. Hippocampal interneurons expressing glutamic acid decarboxylase and calcium-binding proteins decrease with aging in Fischer 344 rats. J. Comp. Neurol. 394:1998;252-269.
51. Trump B.F., Berezesky I.K. Calcium-mediated cell injury and cell death. FASEB J. 9:1995;219-228.
52. 2+ signals in developing rat dorsal root ganglion neurons studied in excised tissue. Brain Res. 635:1994;231-237.
53. Verkhratsky A., Toescu E.C. Calcium and neuronal aging. Trends Neurosci. 21:1998;2-7.
54. Wu C.-K., Mesulam M.-M., Ceula C. Age-related loss of calbindin from human basal forebrain cholinergic neurons. NeuroReport. 8:1997;2209-2213.
55. Yamada T., McGeer P.L., Baimbridge K.G., McGeer E.G. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 526:1990;303-307.
56. Zettel M.L., Frisina R.D., Haider S.E., O'Neill W.E. Age-related changes in calbindin D-28k and calretinin immunoreactivity in the inferior colliculus of CBA/CaJ and C57B1/6 mice. J. Comp. Neurol. 386:1997;92-110.